Company profile: Resonant Medical
1.1 - Company Overview
Company description
- Provider of 3D ultrasound image-guided adaptive radiotherapy products, developing, manufacturing, and commercializing IGRT solutions including Clarity Breast System for precise non-ionizing guidance for boost and conformal breast treatments and Clarity Prostate System for precise non-invasive guidance for prostate.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Resonant Medical
TheraPharm
HQ: Germany
Website
- Description: Provider of monoclonal antibody-based diagnostic and therapeutic biotechnology solutions in hematology, specializing in research, development, and manufacturing for targeted radiation of hematopoietic malignant and non-malignant diseases and lymphoproliferative diseases, conditioning for allogeneic stem cells, and diagnostics of inflammatory diseases and bone marrow metastases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TheraPharm company profile →
EMulate Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage therapeutic devices using proprietary ultra-low radio frequency energy (ulRFE) to elicit therapeutic biological effects. Programs include clinical testing in brain cancer and preclinical work in pain and mental health, advanced by subsidiaries: Cellsana (oncology; Phase III prep for glioblastoma/diffuse midline glioma), Mensana (mental health; Phase I prep), and Indolor (pain; Phase I prep).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EMulate Therapeutics company profile →
Imunon
HQ: United States
Website
- Description: Provider of nucleic acid-based immunotherapy and vaccine platforms that harness the body's immune system, including TheraPlas, a nonviral delivery system for anti-cancer nucleic acid therapies initially targeting advanced ovarian cancer; PlaCCine, a multivalent nucleic acid vaccine platform for infectious diseases and cancer; FixPlas, for universal cancer vaccines; and IndiPlas, for personalized neoepitope cancer vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Imunon company profile →
Avila Therapeutics
HQ: United States
Website
- Description: Provider of covalent drugs for viral infections, cancers, and autoimmune diseases, designing and developing targeted small-molecule therapies including AVL-181, a hepatitis C virus protease inhibitor; partnered with Sanofi-Aventis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avila Therapeutics company profile →
Anchiano Therapeutics
HQ: Israel
Website
- Description: Provider of clinical-stage biopharmaceutical research focused on the discovery and development of novel therapies to treat cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anchiano Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Resonant Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Resonant Medical
2.2 - Growth funds investing in similar companies to Resonant Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Resonant Medical
4.2 - Public trading comparable groups for Resonant Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →